Navepegritide vs TB-500
Overview
Navepegritide and TB-500 are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Navepegritide and TB-500 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Navepegritide | TB-500 | |
|---|---|---|
| Category | Bone & Joint | Bone & Joint |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | — | 2-5 mg |
| Frequency | — | weekly |
| Reported benefits | — | Bone healing, joint mobility, connective tissue support |
| Reported side effects | — | Well-tolerated |
Key differences
Primary use. Navepegritide is categorised under Bone & Joint, while TB-500 falls under Bone & Joint. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Navepegritide: FDA-approved. TB-500: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Typical dosing for Navepegritide is not catalogued. TB-500 is typically dosed at 2-5 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Navepegritide and TB-500 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Navepegritide and TB-500?
- Navepegritide and TB-500 are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status. Navepegritide is FDA-approved for one or more indications, whereas TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Navepegritide used for?
- PEGylated CNP analog for achondroplasia. FDA approved February 27, 2026.
- What is TB-500 used for?
- Connective tissue repair.
- Can you take Navepegritide and TB-500 together?
- Some users combine peptides within a single protocol, but stacking Navepegritide and TB-500 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Navepegritide or TB-500 FDA-approved?
- Navepegritide is FDA-approved for one or more indications. TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Navepegritide — full monograph: mechanism, research, dosing & references
- TB-500 — full monograph: mechanism, research, dosing & references